Saturn V Capital Management »

Cabaletta Bio shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 173k 17.06

More positions owned by Saturn V Capital Management

Crinetics Pharmaceuticals In (CRNX)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Merus N V (MRUS)
Disc Medicine (IRON)
Ascendis Pharma A/s Sponsored Adr (ASND)
Anaptysbio Inc Common (ANAB)
Vaxcyte (PCVX)
Cogent Biosciences (COGT)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Cabaletta Bio

BlackRock
Jennison Associates
Fred Alger Management
Adage Capital Partners GP
T. Rowe Price Investment Management
Vanguard Group
Lynx1 Capital Management
Perceptive Advisors
Bain Capital Life Sciences Investors
VR Adviser
Deerfield Management Company
Commodore Capital
Cormorant Asset Management
Morgan Stanley
Geode Capital Management

View all funds holding Cabaletta Bio